"Diseases and Surgery of the Retina, Macula and Vitreous"

During the past decade, Retina Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Associates" #1 collaborator was "Pfizer" with 2 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Retina Associates" are "Geographic Atrophy" (1 trials), "Macular Degeneration" (1 trials), "Neovascular (Wet) Age-related Macular Degeneration (AMD)" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Retina Associates" in a lesser frequency.

Most popular intervention types in "Retina Associates" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "pegaptanib sodium" (2 trials), "ABP 938" (1 trials), "APL-2" (1 trials), "Aflibercept" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Retina Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Retina Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Retina Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".